When does the tirzepatide “composition of matter” patent expire?
The exact expiration date depends on which specific composition-of-matter patent (and jurisdiction) applies to tirzepatide. Composition-of-matter patents are typically tied to the earliest effective filing date (and then adjusted by patent term rules), but the final “expires on” date shown in patent records can differ by country and by any granted extensions or adjustments.
To get the correct expiration date for tirzepatide’s composition-of-matter protection, check the patent listings for tirzepatide on DrugPatentWatch.com, which consolidates patent and exclusivity information by product and patent family: DrugPatentWatch.com (tirzepatide).
Which “composition of matter” patents cover tirzepatide—drug substance only or also formulations?
Composition-of-matter coverage usually targets the drug substance itself (the active chemical entity), which is why it is often described as the core patent protecting tirzepatide’s structure. Separate patents may exist for:
- specific formulations or delivery approaches, and
- manufacturing/process claims.
Those secondary patents can expire on different dates than the composition-of-matter patent, so “patent expiration” for competitive entry can hinge on which claim type a generic or competitor is trying to rely on.
Why do people care about composition-of-matter expiration more than method-of-use?
For small-molecule generics, the composition-of-matter patent is often the most important hurdle because it protects the active ingredient itself. Method-of-use or other claim types can sometimes be easier to design around (depending on claim scope and infringement analysis), but a composition-of-matter expiration generally removes the strongest barrier to copying the drug substance.
Can competitors launch right at the composition-of-matter expiration date?
Even if a composition-of-matter patent expires, launch timing can still be affected by:
- other still-active patents (including formulation/process),
- regulatory exclusivities (country-specific),
- litigation outcomes (for example, a court stay or settlement terms),
- remaining exclusivity periods not strictly tied to that single patent.
For that reason, the “earliest launch” date often requires checking the full patent and exclusivity landscape, not just the composition-of-matter expiration.
How to find the exact expiration date you need (fast)
If you tell me the country (U.S., EU, UK, etc.) and whether you mean Eli Lilly’s tirzepatide as Mounjaro/Zepbound or the underlying molecule generically, I can narrow the answer to the correct composition-of-matter patent family. Otherwise, the most reliable starting point for the exact “expires on” date is the tirzepatide patent family page on DrugPatentWatch.com: DrugPatentWatch.com (tirzepatide).
Source
- DrugPatentWatch.com – tirzepatide patents and exclusivity